AtriCure, Inc. Files Q1 2025 10-Q

Ticker: ATRC · Form: 10-Q · Filed: Apr 30, 2025 · CIK: 1323885

Sentiment: neutral

Topics: 10-Q, financials, medical-devices

TL;DR

AtriCure's Q1 2025 10-Q is in. Check financials.

AI Summary

AtriCure, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the first quarter of 2025. Key financial data and operational updates are presented for the company, which is involved in surgical and medical instruments.

Why It Matters

This filing provides investors and stakeholders with the latest financial performance and operational status of AtriCure, Inc., crucial for understanding the company's trajectory in the medical device sector.

Risk Assessment

Risk Level: medium — As a medical device company, AtriCure faces inherent risks related to product development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of AtriCure, Inc.?

AtriCure, Inc. is primarily involved in the Surgical & Medical Instruments & Apparatus industry, as indicated by its SIC code 3841.

For which fiscal period is this 10-Q filing?

This 10-Q filing is for the period ended March 31, 2025.

What is the company's fiscal year end?

AtriCure, Inc.'s fiscal year ends on December 31.

Where is AtriCure, Inc. headquartered?

AtriCure, Inc. is located at 7555 Innovation Way, Mason, OH 45040.

What is the SEC file number for AtriCure, Inc.?

The SEC file number for AtriCure, Inc. is 000-51470.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on April 30, 2025 regarding AtriCure, Inc. (ATRC).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing